Ibex CEO Robert Dechant sells $434,338 in common shares

Published 16/06/2025, 23:04
Ibex CEO Robert Dechant sells $434,338 in common shares

Robert Dechant, the Chief Executive Officer of IBEX Ltd (NASDAQ:IBEX), recently executed a significant transaction involving the sale of company stock. According to a Form 4 filing with the Securities and Exchange Commission, Dechant sold 15,000 common shares on June 13, 2025. The shares were sold at a weighted average price of $28.9559, resulting in a total transaction value of approximately $434,338. The transaction comes as IBEX shares have delivered an impressive 78% return over the past year, with the stock currently trading at $28.33.

This transaction was executed in multiple trades at prices ranging from $28.6828 to $29.355. Following the sale, Dechant retains ownership of 198,633 shares of IBEX Ltd. The transaction was carried out under a pre-established trading plan, often referred to as a 10b5-1 plan, which allows company insiders to sell a predetermined number of shares at a predetermined time. With a market capitalization of $379 million and a P/E ratio of 12, InvestingPro analysis suggests IBEX is currently trading below its Fair Value.

Investors and market watchers will note this transaction as part of their ongoing assessment of IBEX Ltd’s stock performance and executive actions. For deeper insights into IBEX’s valuation and 11 additional key ProTips, visit InvestingPro.

In other recent news, IBEX Ltd reported record revenue for Q3 2025, reaching $140.7 million, an 11% increase from the previous year. The company also posted an adjusted earnings per share (EPS) of $0.82, surpassing market forecasts. Following this earnings announcement, IBEX raised its full-year revenue guidance to $540-$545 million. In other developments, IBEX appointed Ricky Fields as the Global Head of Business Development for its AI platform, Wave iX, aiming to enhance its market position in AI-driven customer experience solutions. Meanwhile, Baird analysts downgraded IBEX’s stock rating from Outperform to Neutral, setting a price target of $30. This adjustment was attributed to the stock’s significant appreciation over the past year. Despite the downgrade, Baird analysts remain optimistic about IBEX’s growth potential, noting the company’s successful market share gains and strategic advancements in AI.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.